Pfizer and Protalix BioTherapeutics Derive GE Carrot Cells for Gaucher Disease Treatment
May 11, 2012| |
A new announcement from Pfizer, Inc. and ProtalixBioTherapeutics said that the U.S. Food and Drug Administration (FDA) has approved the ELELYSO™ for injection. This new drug is for the enzyme replacement therapy (ERT) of adults with type 1 Gaucher disease.
ELELYSO™ is the first plant cell-based ERT that FDA has approved. This new drug is derived from ProCellEx® using genetically engineered carrot cells. ProCellEx® is Protalix's proprietary manufacturing system.
Read more about ELELYSO™ and the plant cell manufacturing system at http://www.pfizer.com/news/press_releases/pfizer_press_release.jsp?guid=20120501007295en&source=RSS_2011&page=1.
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- FAO Director-General Warns of Horn of Africa, Sahel Funding Gap
- Biotechnology, Key to Realizing Africa's Full Agricultural Potential, says Ghana Minister
- FAO: Use Your Oil Resources to Improve Agriculture in Africa
- CGIAR Program to Improve Maize Opens Call for Proposals
- Cornell Researcher Works to Reduce Aluminum Toxicity in Rice
- NSF Grant Supports Study on Hidden Soybean Genes
- IFIC Survey on Consumers' Perception of Food Tech
- New Source of Biofuel from Ceres Sweet Sorghum Hybrids
- Consumer Attitude toward GM Foods in South Korea
- New Nematode-Resistant Wheat
- PAU Experts Urge Use of Biotechnology in Pest Management
- ADB Report: Comprehensive Approach Must Be Implemented for Food Security and Poverty Reduction in Asia
- Philippine Agri Experts Underscore Need for Alternative Bt Eggplant Technology
- UWA Crop Root Study to Boost Grain Production
- China's Ten Measures to Promote Transformation of Traditional Agriculture
- QUAAFI-Pioneer Hi-Bred Partners on Predicting Crop Yield Technology
- JHI Receives £1.25M Grant for Barley Research
- Moss Detects Air Pollution
- Undue Delays in the EU Approval of Safe GM Products
-
Research Highlights
- Pollen Allergic Risk Assessment of GM Pepper and GM Chinese Cabbage
- Effects of Bt Maize Feeds on Immune Response and Digestive Fate of Bt Gene and Protein
- Scientists Compare Nutritional and Phytochemical Properties of GE Pepper and Its Parent Cultivar
-
Beyond Crop Biotech
- microRNAs: Key to Treating Neurodegenerative Diseases
- Scripps Research Institute Finds Protein that Can Silence Genes
- ABSOLUTE: A New View of the Cancer Genome
- Pfizer and Protalix BioTherapeutics Derive GE Carrot Cells for Gaucher Disease Treatment
- CSIRO Student Develops "Spell Checker" for Gene Sequences
- Study Probes How Organisms Evolved Diverse Mechanisms
-
Announcements
- Conference on Czech Contribution to Sustainable Bioeconomy
-
Resources
- Analysis of U.S. Genetically Engineered Crop Regulation and Litigation
- Biotechnology the Invisible Revolution
-
Read the latest: - Biotech Updates (April 10, 2024)
- Gene Editing Supplement (April 10, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet